Tokyo, Nov. 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059800) titled 'Multicenter observational study evaluating minimal residual disease in adult acute myeloid leukemia treatment -FBMTG AML-MRD-' on Nov. 17.
Study Type:
Observational
Primary Sponsor:
Institute - Kyushu University
Condition:
Condition - Acute Myeloid Leukemia
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - In this study, MRD measurements will be performed at the time of initial onset, after completion of each regimen or after completion of chemotherapy, and before allogeneic hematopoietic stem cell transplantation, to verify the significance of MRD measurements ...